Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
You must be a Standard 1 Year member to access this content.
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
You must be a Standard 1 Year member to access this content.
Cooley advised Arcadia on the deal. Arcadia, a technology company empowering energy innovators to fight the climate crisis, announced its $200 million funding round, which values the...
You must be a Standard 1 Year member to access this content.
Cooley advised GrowFlow on the deal. GrowFlow, a business-to-business software as a service (SaaS) platform dedicated to helping customers grow their cannabis businesses, announced its agreement...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Immatics on the deal. Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced its license, development...
You must be a Standard 1 Year member to access this content.
Cooley advised Truebill on the deal, while Paul, Weiss, Rifkind, Wharton & Garrison advised Rocket Companies. Truebill, a personal finance app that helps consumers manage their...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering while Cooley LLP advised NerdWallet. NerdWallet, Inc. completed its initial public offering of 7,250,000 shares of its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Epic on the deal while Cooley LLP represented Byju’s. The global leader in personalized online learning, BYJU’s (backed by General...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Shoreline Biosciences on the deal. Shoreline Biosciences, a biotechnology company developing immunotherapies for cancer and other serious diseases, announced its worldwide strategic collaboration with...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised Iora Health, while Cooley and Ropes & Gray advised One Medical on the deal. Wilson Sonsini Goodrich & Rosati...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Cidara Therapeutics on the deal. Biotechnology company Cidara Therapeutics announced its exclusive worldwide licensing and collaboration agreement with Janssen Pharmaceuticals, Inc., one of...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Datadog on the deal. Datadog, the monitoring and security platform for cloud applications, announced its agreement to acquire Sqreen, a SaaS-based security platform that enables...
You must be a Standard 1 Year member to access this content.
